MITF and melanoma: Furthermore, drug-resistant melanoma cells can dedifferentiate to different extent that is associated with loss of melanoma-specific transcription factor, MITF [123,193], and several studies have suggested that the dedifferentiation status can dictate sensitivity of cancer cells to ferroptosis.